Your browser doesn't support javascript.
loading
Poliovirus-Neutralizing Antibody Seroprevalence and Vaccine Habits in a Vaccine-Derived Poliovirus Outbreak Region in the Democratic Republic of Congo in 2018: The Impact on the Global Eradication Initiative.
Halbrook, Megan; Gadoth, Adva; Mukadi, Patrick; Hoff, Nicole A; Musene, Kamy; Dzogang, Camille; Sinai, Cyrus Shannon; Spencer, D'Andre; Ngoie-Mwamba, Guillaume; Tangney, Sylvia; Salet, Frank; Nyembwe, Michel; Kambamba Nzaji, Michel; Tambu, Merly; Mbala, Placide; Fuller, Trevon; Gerber, Sue K; Kaba, Didine; Muyembe-Tamfum, Jean Jacques; Rimoin, Anne W.
Afiliação
  • Halbrook M; Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA.
  • Gadoth A; Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA.
  • Mukadi P; National Institute of Biomedical Research, Kinshasa P.O. Box 1197, Democratic Republic of the Congo.
  • Hoff NA; Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA.
  • Musene K; Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA.
  • Dzogang C; National Institute of Biomedical Research, Kinshasa P.O. Box 1197, Democratic Republic of the Congo.
  • Sinai CS; Carolina Population Center, University of North Carolina, Chapel Hill, NC 27516, USA.
  • Spencer D; Children's National Research Institute, Center for Genetic Medicine Research, 111 Michigan Avenue NW, Washington, DC 20010, USA.
  • Ngoie-Mwamba G; Expanded Programme for Immunization, Kinshasa P.O. Box 1197, Democratic Republic of the Congo.
  • Tangney S; Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA.
  • Salet F; Bill and Melinda Gates Foundation, Seattle, WA 98109, USA.
  • Nyembwe M; Expanded Programme for Immunization, Kinshasa P.O. Box 1197, Democratic Republic of the Congo.
  • Kambamba Nzaji M; Expanded Programme for Immunization, Kinshasa P.O. Box 1197, Democratic Republic of the Congo.
  • Tambu M; National Institute of Biomedical Research, Kinshasa P.O. Box 1197, Democratic Republic of the Congo.
  • Mbala P; National Institute of Biomedical Research, Kinshasa P.O. Box 1197, Democratic Republic of the Congo.
  • Fuller T; Institute of the Environment and Sustainability, University of California, Los Angeles, CA 90095, USA.
  • Gerber SK; Institute of the Environment and Sustainability, University of California, Los Angeles, CA 90095, USA.
  • Kaba D; Kinshasa School of Public Health, University of Kinshasa, Kinshasa P.O. Box 11850, Democratic Republic of the Congo.
  • Muyembe-Tamfum JJ; National Institute of Biomedical Research, Kinshasa P.O. Box 1197, Democratic Republic of the Congo.
  • Rimoin AW; Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA.
Vaccines (Basel) ; 12(3)2024 Feb 27.
Article em En | MEDLINE | ID: mdl-38543880
ABSTRACT
Despite the successes in wild-type polio eradication, poor vaccine coverage in the DRC has led to the occurrence of circulating vaccine-derived poliovirus outbreaks. This cross-sectional population-based survey provides an update to previous poliovirus-neutralizing antibody seroprevalence studies in the DRC and quantifies risk factors for under-immunization and parental knowledge that guide vaccine decision making. Among the 964 children between 6 and 35 months in our survey, 43.8% (95% CI 40.6-47.0%), 41.1% (38.0-44.2%), and 38.0% (34.9-41.0%) had protective neutralizing titers to polio types 1, 2, and 3, respectively. We found that 60.7% of parents reported knowing about polio, yet 25.6% reported knowing how it spreads. Our data supported the conclusion that polio outreach efforts were successfully connecting with communities-79.4% of participants had someone come to their home with information about polio, and 88.5% had heard of a polio vaccination campaign. Additionally, the odds of seroreactivity to only serotype 2 were far greater in health zones that had a history of supplementary immunization activities (SIAs) compared to health zones that did not. While SIAs may be reaching under-vaccinated communities as a whole, these results are a continuation of the downward trend of seroprevalence rates in this region.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2024 Tipo de documento: Article